Mycoses

Article	Citations
Author Index	69
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	62
T Cell Exhaustion and Function State Correlated With Outcomes in Patients With Intra‐Abdominal Candidiasis	56
	56
Issue Information	47
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	44
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	38
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	36
Issue Information	35
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	32
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	31
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	30
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	28
Aspergillosis and Mucormycosis‐Associated Hospitalizations, United States, 2016–2021	27
The Importance of Early Mycological Clearance of Uncomplicated Candidaemia and Its Implications for Clinical Practice	26
Review Article White Piedra: Review of 131 cases	24
Emergence of Candida auris in intensive care units in Algeria	24
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	24
Physicians' knowledge of invasive fungal disease in China	24
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	23
Issue Information	23
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	21
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	21
Issue Information	21
Issue Information	21

Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	20
Cover Image	20
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	20
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	19
Utility and Pitfalls of β‐D‐Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients	19
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	19
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	19
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	18
Issue Information	18
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	18
	18
Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review	18
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	18
Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.	17
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	17
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	17
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	17
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	17
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance	16
Optimisation of a Murine Infection Model With Trichophyton mentagrophytes for Studying the Pathogenesis of Dermatophytosis	16
Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis	16
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	16
Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Tri	15
Unravelling Voriconazole's Hepatic Metabolism: A Narrative Review on Factors Impacting Voriconazole‐N‐Oxide Exposure	15
Tinea pedis in underrepresented groups: All of Us database analysis	15
	15
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	15
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	15
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	14
Diagnostic performance of noncultural methods for central nervous system aspergillosis	14
Neglected Mycoses in Brazil: A Population‐Based Study of Mortality and In‐Hospital Mortality Over 25 Years	14
Rapid Detection of Fungi in Nail Specimens Using Multi‐Tube Recombinase Polymerase Amplification Assay	14
CARD9 mutations in patients with fungal infections: An update from the last 5 years	13
	13
The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment	13
Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis	13
Epidemiology and Pathogen Shift of Tinea Capitis: A Comparative Analysis of Adults and Children in Nanchang, China (2022–2024)	13
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	13
	13
	13
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	13
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	13
	12
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	12
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	12
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	12
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	12
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	12
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	12
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	12

Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	12
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	12
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	12
Zoonotic and Anthropophilic Trichophyton mentagrophytes Complex Infection in Human: An Update and Narrative Review	12
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	11
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	11
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	11
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	11
Epidemiology of Triazole Resistant Aspergillus fumigatus in Asia: A Systematic Review and Meta‐Analysis	11
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	11
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	11
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	11
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	11
	11
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	11
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	11
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	11
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	11
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	11
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	11
Biologic Therapy and Superficial Fungal Infection Risk in Moderate‐to‐Severe Psoriasis: A Meta‐Analysis	10
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	10
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	10
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	10
	10
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	10
Aspergillus nodules: Natural history and the effect of antifungals	10
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	10
Issue Information	10
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	10
Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts	9
Expert recommendations for prevention and management of Candida auris transmission	9
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	9
	9
Issue Information	9
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	9
Prevalence Rates, Species Distribution and Antifungal Susceptibility of Rare Candida and Related	9
	9
Biocide Response of Candida auris	9
Infrared Spectroscopy as a Promising Tool for Diagnosing and Typing Human Pathogenic Fungi	9
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species‐Specific IgG	9
Global Emergence of Antifungal‐Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytesITS Genotype VIII): A Genomic Investigation In	9
Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study	9
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	8
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	8
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	8
Characterisation of Antifungal Prophylaxis and Therapy Among Inpatients With Haematological Malignancies in Non‐Research Clinical Setting: A Multicentre Italian Experience	8
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	8
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	8
Diagnostic Performance of Sōna GM LFA in Pulmonary Infections Caused by Different Aspergillus Species	8
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	8
Paediatric cutaneous mucormycosis: A case report and review of the literature	8
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	8
Issue Information	8
Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China	8
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	8
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	8
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	8
Updated estimation of the burden of fungal disease in Vietnam	8
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	8
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	8
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	8
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	8
Issue Information	8
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	8
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	8
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	8
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	8
Coccidioidomycosis in Oklahoma: A retrospective case series	8
	8
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	8
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	8
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	8
The First Isolation of Multiple Antifungal‐Drug‐Resistant Trichophyton Rubrum in China and the Novel Resistance Mechanism	8
Abstracts	8
	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	7
	7
Altered skin fungal and bacterial community compositions in tinea capitis	7

Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China	7
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	7
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	7
Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production	7
Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany	7
Issue Information	7
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	7
Airway Mycobiota—Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study	7
Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells	7
Time and cost‐efficient identification of Trichophyton indotineae	7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	7
	7
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real‐life settings: A nationwide population‐based cohort study	7
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital	7
	7